Skip to main navigation Skip to search Skip to main content

A Phase 2, Multicenter, Randomized, Active-controlled Study to Assess the Safety and Efficacy of ANG003 at Two Different Dose Levels in Subjects with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis

Project: Research project

Project Details

StatusActive
Effective start/end date3/1/26 → 2/29/36

Funding

  • ANAGRAM THERAPEUTICS, INC